NuCicer named to 2026 Norrsken100, the list of most promising early-stage companies solving global problems at scale. Founded to be the "Nobel Prize for impact," the Norrsken100 draws from 1,400+ nominations. Honorees are vetted for having a product in market and using scalable technology to solve massive global environmental and social challenges with measurable impact.
Sonothera named one of the 2026 Winners of the Endpoints 11 Awards, showcasing biotech’s most exciting startups.
Attovia Therapeutics (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need, announced the pricing of its upsized initial public offering.
NuCicer Introduces Nuchi, announced Nuchi™ , a whole new class of high-protein chickpeas. Nuchi (“new + chickpea”) is the product of foundational plant genetics research accelerated by NuCicer's AI-driven genomic modeling and speed-breeding technology.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
